After injections stopped the ELTD1‐EV injected tumours initially grew significantly more slowly (Day 24–34) but in the final stages of growth the ELTD1‐EV injected tumours grew significantly faster (Day 34–41), eventually catching up with the controls and reaching a similar size (Figure 5a,b). This evidence concerns the gene ADGRL4 and neoplasm.